Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma.
Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma.
Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.
Company Details
- Employees
- 15
- Founded
- 2020
- Address
- Lille, Fr
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- hemerion.com
- Keywords
- IT Consulting.
- HQ
- Lille
Hemerion Therapeutics Questions
Hemerion Therapeutics's website is hemerion.com
Hemerion Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/hemerion-therapeutics
Hemerion Therapeutics has
15 employees.
View email and phone details for 15
employees at Hemerion Therapeutics.
Hemerion Therapeutics's industry is
Biotechnology Research
Hemerion Therapeutics's categories are Biotechnology Research
Hemerion Therapeutics's founding year is 2020
